Atlas Trials

Cannabinoids for Taxane Induced Peripheral Neuropathy

Clinical trial NCT03782402 · TERMINATED

Trial details

NCT number
NCT03782402
Sponsor
New York State Psychiatric Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Chemotherapy-induced Peripheral Neuropathy
Start date
2019-09-01
Primary completion
2021-08-30
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.